Tatsuo Oyake

Yahaba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients.

Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients.

Journal: International journal of hematology

Published: April 01, 2026

Control of Fungal Infections After Chemotherapy for Hematologic Diseases and After Hematopoietic Stem Cell Transplantation.

Control of Fungal Infections After Chemotherapy for Hematologic Diseases and After Hematopoietic Stem Cell Transplantation.

Journal: Medical mycology journal

Published: March 01, 2026

Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study.

Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study.

Journal: International journal of hematology

Published: February 24, 2026

Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.

Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 10, 2026

Adult T-cell leukemia/lymphoma treated with mogamulizumab followed by allogeneic stem cell transplantation after bridging therapy with valemetostat

Adult T-cell leukemia/lymphoma treated with mogamulizumab followed by allogeneic stem cell transplantation after bridging therapy with valemetostat

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.

Journal: Frontiers in oncology

Published: August 17, 2025

Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Primary Plasma Cell Leukemia in Japan.

Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Primary Plasma Cell Leukemia in Japan.

Journal: Transplantation and cellular therapy

Published: June 24, 2025

Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine-venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net.

Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine-venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net.

Journal: Blood cancer journal

Published: May 12, 2025

Prognostic predictors of newly diagnosed Diffuse large B-cell lymphoma treated with R-THP-COP regimen.

Prognostic predictors of newly diagnosed Diffuse large B-cell lymphoma treated with R-THP-COP regimen.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 02, 2025

Comparative analysis of allogeneic hematopoietic cell transplantation in patients with therapy-related and de novo acute promyelocytic leukemia A retrospective study.

Comparative analysis of allogeneic hematopoietic cell transplantation in patients with therapy-related and de novo acute promyelocytic leukemia A retrospective study.

Journal: Scientific reports

Published: December 23, 2024

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphoma.

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: July 31, 2024

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.

Journal: Hematology (Amsterdam, Netherlands)

Published: April 16, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026